JPRN-UMIN000008186
Recruiting
未知
eutralizing antibody of Interferon beta on multiple sclerosis (Multi-center clinical studies) - Neutralizing antibody of IFN-beta on MS (Multi-center clinical studies)
ConditionsMultiple sclerosis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Multiple sclerosis
- Sponsor
- Yokohama City University
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Not MS patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
eutralizing Antibodies to Interferon beta in patients treated with Rebif New Formulation - NAb development with RNFIFNß-naïve patients fulfilling Poser or McDonald criteria for CDMS or MS and in whom a decision has been made to initiate treatment with RNF (Rebif New Formulation).MedDRA version: 9.1Level: LLTClassification code 10028245Term: Multiple sclerosisEUCTR2008-008554-23-SEThe Multiple Sclerosis Research Group, Department of Clinical Neuroscience100
Active, not recruiting
Not Applicable
REsPons på interferon-Alfa hos InterfeRon-ß-neutraliserende antistof-positive patienter med multipel sklerose - REPAIRMultiple SclerosisMedDRA version: 12.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisEUCTR2009-016824-29-DKDansk Multipel Sclerose Center10
Active, not recruiting
Phase 1
Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patientsSARS-CoV 2 infection characterized by a National Early Warning Score lower or equal to 2 and symptoms present for less than 7 daysMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862MedDRA version: 20.0Level: PTClassification code 10070255Term: Coronavirus test positiveSystem Organ Class: 10022891 - InvestigationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-003872-42-ITIstituto di Farmacologia Traslazionale - CNR60
Active, not recruiting
Not Applicable
Analysis of the antibody level against interferon beta before and after increase of dose in MS therapy - Interferon beta dose and antibodyMultiple sclerosisEUCTR2005-001008-37-SESahlgrenska University Hospital100
Completed
Not Applicable
Assay for detection of neutralizing antibodies against interferon-beta in multiple sclerosismultiple sclerosisJPRN-UMIN000005797Department of Neurology, Tohoku University School of Medicine100